Effects of cholestyramine and lovastatin upon plasma lipids and egg yolk cholesterol levels of laying hens

ABSTRACT

The purpose of this study was to evaluate the effect of cholestyramine and lovastatin, lipid-lowering agents, upon egg quality, reproductive performance, plasma lipids and egg yolk cholesterol levels of Shaver laying hens. Twenty-six-weeks-old hens were fed basal diet without animal products containing 0.2 per cent cholestyramine (COL1), 0.3 per cent cholestyramine (COL2) or 0.005 per cent lovastatin (LOV) for 6 weeks. If was observed that the supplementation of the significant reduction (p<0.05) in egg weights. No significant changes were observed on plasma lipids, and egg yolk cholesterol remained unchanged with the addition of the drugs